An interventional study of Prone position in Right Ventricular Function, Prone Position and Atelectasis, sponsored by Sahlgrenska University Hospital. Not yet recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Sahlgrenska University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Pulmonary Atelectasis with a site in Sweden — 5 open to participants now, 5 under way, none of them phase 3. Pulmonary Atelectasis · Sweden.
Among the 16 studies in Pulmonary Atelectasis with a site in Sweden, this one is the 2nd largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 10 with no phase, and was the 15th registered.
378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.
Browse Pulmonary Atelectasis studies →5 of the 16 studies in Pulmonary Atelectasis with a site in Sweden are open now. Recruiting first, the newest first:
Vastra Gotaland Region · Sites in Sweden
Karolinska University Hospital · Sites in Sweden
Ages 18–100 · Healthy volunteers
Region Örebro County · Sites in Sweden
Ages 18+ · Men only
Karolinska Institutet · Sites in Sweden
Ages up to 2 days
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 51 Pulmonary Atelectasis studies recruiting now, 20 (39%) set no upper age limit and 23 (45%) stop at 75 or younger; 24 take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 70 is above the median of 60 across 268 interventional studies indexed under Pulmonary Atelectasis.
Median enrollment 30 across the 10 interventional studies, 95 across the 6 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 16 has an industry lead sponsor. The 8 most frequent:
Sahlgrenska University Hospital is the lead sponsor of 264 studies on the registry; 69 are open to participants now.
Sahlgrenska University Hospital has 2 studies filed under Pulmonary Atelectasis — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 16 studies in Pulmonary Atelectasis with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Right ventricular failure (RVF) is a common complication to cardiac surgery, which is associated to mortality, kidney failure, stroke, prolonged mechanical ventilation and ICU stay. The right ventricle is particularly vulnerable to an increased afterload. By increasing pulmonary vascular resistance (PVR), atelectasis might mitigate a negative effect on the right ventricle.
Recruitment maneuvers have been shown to resolve atelectasis and improve hemodynamics by increasing cardiac output and lowering PVR. However these maneuvers transiently raise airway pressures, which in turn increases right ventricular afterload, a situation often poorly tolerated by patients with RVF.
Prone position is used in patients with respiratory failure and has been shown to decrease mortality in patients with ARDS. Prone position decreases atelectasis and moves ventilation dorsally. In ARDS it also seems to mediate beneficial hemodynamic effects such as an increase in cardiac output and a decrease in PVR.
The investigators hypothesis is that prone position early after cardiac surgery will increase cardiac output by recruitment of atelectasis and thereby decrease PVR.
Recruitment and consent:
Patients will be screened for participation no later than the day before surgery. Potential participants will be given written and verbal information regarding the study and time to ask questions and consider their participation.
Randomization:
After end of surgery, at baseline in the ICU, patients will be randomly allocated (1:1 ratio) to supine position and prone position. Block randomization with variable block sizes will be performed with sequentially numbered, opaque, sealed envelopes. All performed by Statistiska konsultgruppen. Patient stratification according to cardiac index at end-surgery will be performed to ensure similar allocation of patients with cardiac index \<2.2 L/min/m2 in each group. The investigator who enrolls study participants will not have access to the random allocation sequence.
Sample Size:
Based on previous studies of cardiac surgery or prone position an a priori sample size calculation was performed using a two-sample t-test comparison of means, with equally sized independent groups. With intention to detect at least a 20% difference in cardiac index in the intervention group and with 80% power, 0.05α, estimated mean CI 2.6(0.9 SD) in control group, and CI 3.2(0.9 SD) in the prone group, the estimated sample size was n=70, divided in 2 equally large groups. As patients intermittently require recurring surgery due to i.e. bleeding, patients might be excluded after inclusion. Enrolment continues until 70 participants have completed the entire study protocol.
Interim analysis:
Given uncertainty regarding expected baseline cardiac index and its standard deviation in the study population, an interim sample size reassessment will be performed after inclusion of 40% of the planned sample (n=28). The interim analysis will be limited to re-estimation of mean and standard deviation of baseline cardiac index, and will not assess treatment effects. If the observed assumptions differ substantially from those used in the original sample size calculation, the required sample size may be adjusted to preserve the planned statistical power of the study.
Description of method:
In included patients, anesthesia will be performed with Propofol, Fentanyl and Sevoflurane. As per clinical routine patients will have a central venous catheter, 1-2 arterial catheters, TEE probe and endotracheal tube inserted. Study participants will also get a pulmonary artery catheter (PAC) inserted prior to surgery to facilitate measurement of cardiac output using thermodilution and PVR. Body surface area is calculated using the Mosteller formula.
During surgery, after CPB is weaned, the attending anaesthesiologist is instructed to refrain from additional recruitment maneuvers and a PEEP >8 cmH2O. Unless FiO2 is >80% to maintain adequate oxygenation of the patient or the anaesthesiologist deems it necessary.
When surgery is finished, the patient will be moved to the Thoracic ICU. Ventilation performed with a Maquet Servo-U (Getinge, SE) is set to volume control, tidal volumes of 6 ml/kg IBW with a respiratory rate of 12-18 and PEEP 8 cmH2O. Data collection occurs in all patients in supine position (0). Hereafter the study group is turned to prone while the control group remains in supine position.
60 minutes after proning data is again collected (t1), whereafter a recruitment maneuver is performed by gradually increasing PEEP during 2,5 minutes in 6 steps to 20 cmH2O during. After 30 seconds PEEP is decreased in 6 steps during 2,5 minutes to reach PEEP 8 cmH2O. Data is collected after the recruitment maneuver (t2) and one hour after (t3), adding up to a total of 2 hours and 15 minutes in supine or prone position. The patients in prone position are turned to supine position and the last data collection occurs (t4). In total 5 time points for data collection. Postoperative care will now continue as per routine care. Patients will be extubated as soon as possible according to clinical routine and eventually discharged from the ICU.
Since a recruitment maneuver transiently increases right ventricular afterload there is a possibility not all patients will tolerate the recruitment maneuver as described above. As per clinical practice the level of airway pressures during recruitment will be adjusted when needed to avoid adverse effects.
Discontinuation of the intervention:
In order to minimize harm the following set criteria will be used to discontinue prone position:
Blinding:
After allocation to supine or prone position neither the investigator, nor ordinary ICU personnel, will be blinded due to safety and impracticalities. Patients are blinded due to being under general anaesthesia during randomization until weaning from mechanical ventilation (after the study protocol is completed).
Data collection:
A site investigator will record data using a software developed by Getinge from the respirator to a designated research computer. All other data and variables, mentioned above, will be collected from the participants digital chart and real time monitoring (Philips IntelliVue \& BD Hemosphere).
Data management:
Collected data is pseudonymized and stored on a password protected designated research computer. Only authorized study personnel have access to the computer.
Original records, including signed written consent, are kept with strict confidence. These records will be kept in a secure, locked and limited access location at Sahlgrenska Univeristy Hospital during the study and after completion for an additional 10 years. At inclusion each patient is pseudonymized by receiving a participant ID, which is used in all data files.
The criteria were revised on the registry on Oct 23, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Control group. Will remain in supine position for the whole protocol.
Will be turned to prone position after baseline data collection (0) and return to supine position before the final data collection (t4).
Procedure: Prone position
Prone position is applied in the intervention group immediately after randomization, patients will be prone for a total of 2 hours and 15 minutes. During this time 3 data collection points occur (t1, t2 \& t3).
Cardiac Index
L/min/m2
Time frame: 1 hour after baseline
PVRi
Difference between and within groups
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Cardiac Index
Difference between and within groups
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
RV pressure
Looking at differences of right ventricular blood pressure between groups at all timepoints
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Driving Pressure
Plateau Pressure - PEEP
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
PaO2:FiO2
Within and between groups
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Vasopressor dose
Difference of actual vasopressor dose within and between groups at all timepoints
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Inotrope dose
Difference of actual inotrope dose between groups at all timepoints
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
CVP
Difference in central venous pressure within and between groups at all timepoints
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
PAP
Difference in pulmonary artery pressure within and between groups at all timepoints
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
PCWP
Difference in pulmonary capillary wedge pressure within and between groups at all timepoints
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Systemic blood pressure
Difference in systemic blood pressure within and between groups at all timepoints
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Heart rate
Difference in heart rate within and between groups at all timepoints
Time frame: 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Chest drain output
Total amount from all chest drains between Baseline and t4.
Time frame: 2 hours 45 minutes after baseline
ICU length of stay
Time from start to end of the ICU visit, measured in days.
Time frame: Perioperative
Time to extubation
Time from arrival to the ICU until patient's endotracheal tube is removed (extubation). Measured in hours.
Time frame: Perioperative
Harms
Adverse events. Severity graded: Mild, Moderate, Severe \& Life-Threatening. Causality: Due to prone position? Other reason?
Time frame: At any point in time from Baseline to 2 hours and 45 minutes after Baseline.
RV contractility during recruitment maneuver
Measured as dP/dt (mmHg/s). Maximum upslope of the pressure waveform measured at the RV.
Time frame: During recruitment (1 hour after baseline).
Physiological dead space
Eventual exploratory outcome. Analysis of VD/VT using Enghoff-modified Bohr equations.
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Subgroup analysis of Cardiac Index
Patients with perioperative or postoperative diagnosed RVF according to a published standardized definition will be analyzed separately in a subgroup analysis.
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Subgroup analysis of PVRi
Patients with perioperative or postoperative diagnosed RVF according to a published standardized definition will be analyzed separately in a subgroup analysis.
Time frame: At baseline. 1 hour after baseline. 1 hour 15 minutes after baseline. 2 hours 15 minutes after baseline. 2 hours 45 minutes after baseline.
Plan to share: No — As of now there aren't any plans to share IPD. However if good ideas for further studies on this data by other researchers appear, our plan to share IPD might change.
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for May 2029, 31 months later.
Of 155 non-industry interventional studies with no phase under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 31 months is above that.
Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 5 and three quarters within 21.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: start Sep 2026 → Oct 2026, primary completion May 2028 → May 2029 and completion Oct 2028 → Oct 2029.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sahlgrenska University Hospital →